---
figid: PMC7215568__ijms-21-02967-g004
figtitle: MNK in hematological cancers
organisms:
- Homo sapiens
- Mus musculus
- Enterovirus
organisms_ner:
- Homo sapiens
- Mus musculus
- Drosophila melanogaster
- Arabidopsis thaliana
pmcid: PMC7215568
filename: ijms-21-02967-g004.jpg
figlink: pmc/articles/PMC7215568/figure/ijms-21-02967-f004/
number: F4
caption: 'MNK in hematological cancers. Most of the MNK inhibitors act inhibiting
  eIF4E phosphorylation, although there are some exceptions. Niclosamide, an anthelminthic
  drug, affects eIF4E phosphorylation acting upstream ERK/MNK/eIF4E pathway. FL3 inhibits
  PHB affecting MNK/eIF4E and also eIF4A and therefore eIF4F complex formation. QL-X-138
  targets BTK affecting PI3K/AKT/mTOR pathway and MNK1 phosphorylation. CGP57380,
  pyridine derivatives and SEL201 are also used in combination with rapamycin to enhance
  mTOR-targeted therapy. Red squares: inhibitors.'
papertitle: Deeping in the Role of the MAP-Kinases Interacting Kinases (MNKs) in Cancer.
reftext: Celia Pinto-DÃ­ez, et al. Int J Mol Sci. 2020 Apr;21(8):2967.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.950356
figid_alias: PMC7215568__F4
figtype: Figure
redirect_from: /figures/PMC7215568__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7215568__ijms-21-02967-g004.html
  '@type': Dataset
  description: 'MNK in hematological cancers. Most of the MNK inhibitors act inhibiting
    eIF4E phosphorylation, although there are some exceptions. Niclosamide, an anthelminthic
    drug, affects eIF4E phosphorylation acting upstream ERK/MNK/eIF4E pathway. FL3
    inhibits PHB affecting MNK/eIF4E and also eIF4A and therefore eIF4F complex formation.
    QL-X-138 targets BTK affecting PI3K/AKT/mTOR pathway and MNK1 phosphorylation.
    CGP57380, pyridine derivatives and SEL201 are also used in combination with rapamycin
    to enhance mTOR-targeted therapy. Red squares: inhibitors.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - BTK
  - EPHB2
  - MAPK1
  - MAPK3
  - MTOR
  - RPTOR
  - EIF4E
  - EIF4E2
  - EIF4E3
  - DLX4
  - EIF4EBP1
  - RPS6KB1
  - MKNK1
  - MKNK2
  - EIF4G1
  - EIF4G2
  - EIF4G3
  - EIF4A1
  - EIF4A2
  - EIF4A3
  - PHB1
  - Btk
  - Ephb2
  - Mapk1
  - Eif4e
  - Eif4ebp1
  - Rps6kb1
  - Mknk1
  - Mapk3
  - Mknk2
  - Phb1
  - Erk7
  - rl
  - Crtc
  - eIF4E1
  - eIF4E7
  - eIF4E4
  - eIF4E5
  - eIF4E3
  - eIF4E6
  - eIF4EHP
  - Thor
  - S6k
  - slou
  - vnd
  - eIF4G2
  - eIF4G1
  - CG9932
  - eIF4A
  - CG7483
  - KNAT1
  - EIF4G
  - PHB
  - Niclosamide
  - Rapamycin
  - CGP57380
  - Pyridine
  - BAY1143269
  - Cercosporamide
  - NUCC-54139
  - Benzofuran
  - Cyclopropanecarboxamide
  - Hematological cancers
---
